The SU2C–Lustgarten Foundation Pancreatic Cancer Convergence Research Team is investigating why a small group of pancreatic cancer patients survive for many years after diagnosis, and developing tools to devise new cancer vaccines that will turn all pancreatic cancer patients into long-term survivors.